Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Ark Therapeutics selects new broker and financial adviser

Ark Therapeutics selects new broker and financial adviser

17th December 2010

Ark Therapeutics has moved to strengthen the foundations of its future growth by appointing Matrix Corporate Capital as its new broker and financial adviser.

The newly-selected broker has extensive experience working with the life sciences sector and offers the medical technology firm a strong range of integrated investment banking services.

Martyn Williams, chief executive officer of Ark Therapeutics, stated that Matrix has been hired with immediate effect due to its proven credentials, which he believes will help to underpin "the next stage in Ark's development".

He explained: "It is critical for us that the broker we appoint is committed to the sector and is able to offer first-class advisory, research and distribution capabilities."

In September 2010, the company detailed extensive plans to restructure its business operations in order to guarantee future expansion.

These include a new focus on areas of research such as its Neuropilin-1 and Foetal Growth Restriction programmes, as well as the upscaling of its facilities in Kuopio, Finland.ADNFCR-8000103-ID-800298463-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.